Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave.
Ryan Allway June 22nd, 2021 Psychedelics To drive brand awareness of, and access to, HaluGen’s Psychedelics Genetic Test Kit Vancouver, British Columbia–(Newsfile Corp. – June 22, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )